Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call Transcript [Seeking Alpha]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Seeking Alpha
Wave Life Sciences Ltd. (NASDAQ:WVECompany ParticipantsKate Rausch - Head, Investor RelationsPaul Bolno - President and Chief Executive OfficerMike Panzara - Chief Medical Officer, Head, Therapeutics Discovery and DevelopmentKyle Moran - Chief Financial OfficerConference Call ParticipantsJoon Lee - Truist SecuritiesSalim Syed - MizuhoLisa Walter - RBCAlex Thompson - StifelMani Foroohar - SVB SecuritiesSuji Jeong - JefferiesOperatorGood morning and welcome to the Wave Life Sciences First Quarter 2022 Financial Results Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded and webcast.I will now turn the call over to Kate Rausch, VP of Investor Relations and Corporate Affairs at Wave Life Sciences. Please go ahead.Good morning and thank you for joining us today to discuss our recent business progress and review Wave’s first quarter 2022 financial results. Joining me today with prepared remarks are Dr. Paul Bolno, Wave’s President and C
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024GlobeNewswire
- Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)GlobeNewswire
- Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA EditingGlobeNewswire
WVE
Earnings
- 3/6/24 - Beat
WVE
Sec Filings
- 4/29/24 - Form 10-K/A
- 4/5/24 - Form 4
- 4/3/24 - Form 144
- WVE's page on the SEC website